## [Life Sciences and Healthcare](/en_GB/services/life-sciences-and-healthcare) The Garrigues Life Sciences & Healthcare team has extensive experience in providing **professional advice to clients in the pharmaceuticals, healthcare, biotechnology and life sciences sector** taking a multidisciplinary and client-centric approach. We advise on the **different branches of business law**, such as regulatory compliance, commercial contracts, public procurement from pharmaceutical companies and manufacturers of medical devices, intellectual property, mergers, acquisitions and financing, data protection, tax law, antitrust law, litigation and product liability, among others. Our clients include pharmaceutical companies and biotech firms; manufacturers and marketers of medical devices; producers of functional foods; manufacturers and marketers of cosmetics; public and private hospitals; distributors; entities involved in research and development in the sector; investment funds; foundations; and companies and business groups in the pharmaceutical, healthcare and biotechnology sector, and in the life sciences sector in general. ## Our services - **Advice on compliance** and regulatory issues affecting the sector. **Public procurement**. - Pricing and reimbursement for medicinal products and medical devices. - Advice on **aid, subsidies, hospital finance** and other related issues. - **Mergers, acquisitions** and other transactions, mainly **joint ventures** using corporate vehicles, mergers, spin-offs and restructurings of business groups, venture capital investments in all phases and funding rounds, special financial transactions or public offerings of securities. - Protection of **patents and trademarks.** - Patent infringement and invalidity proceedings, technology transfer, obtainment of strategic patents at international level and submission of challenges to patent applications. - Notification procedures for concentrations and in relation to vertical and horizontal agreements. - Digital health, **data protection and privacy.** - **Comprehensive tax advice.** - Drafting and review of **contracts**, including manufacturing and distribution contracts, clinical trials, etc. - **Antitrust law**, procedures for notification of concentrations and advice on vertical and horizontal agreements. - Representation and defense of clients in **administrative and court proceedings.** ## Global head ![](/sites/default/files/styles/medium/public/team/photo/10000844.jpg?itok=-NjfKDZv) [José Fernández-Rañada ](/en_GB/team/jose-fernandez-ranada-lopez-doriga) ![](/themes/custom/garriguestheme/img/iconos/telefono-contacto.svg)+34 91 514 52 00 ![](/themes/custom/garriguestheme/img/iconos/ubicacion-contacto.svg)[Madrid](https://www.garrigues.com/en_GB/office/madrid) ![](/themes/custom/garriguestheme/img/iconos/email-contacto.svg)[Contact](mailto:jose.fernandez-ranada@garrigues.com) [Find more professionals](../../en_GB/team-service/1429) ## Other Garrigues services Seleccionar el servicio ServiceAdministrative and Constitutional LawAgribusiness and FoodAutomotiveBanking and FinanceCorporate and M&ACriminal Law and Internal InvestigationsData Economy, Privacy and CybersecurityDispute Resolution: Litigation and ArbitrationEnergyEU and Antitrust LawFamily BusinessFashion LawFinancial RegulationHuman Capital ServicesInfrastructureInsuranceIntellectual PropertyLabor and EmploymentLife Sciences and HealthcareMedia and EntertainmentPlanning, Zoning and EnvironmentPrivate EquityReal EstateRestructuring and InsolvencySecurities MarketsSportsStartups & Open innovationSustainabilityTaxTechnology, Communications and DigitalTourism and HotelsTransport, Logistics and Shipping ## Publications - 05 / 07 / 2026 [### Mexico: The amendment to the Health Supplies Regulations strengthens the protection of pharmaceutical innovation by introducing patent term compensation and clinical data exclusivity](/en_GB/new/mexico-amendment-health-supplies-regulations-strengthens-protection-pharmaceutical-innovation) On April 24, an amendment to the Health Supplies Regulations (Reglamento de Insumos para la Salud – RIS) was published, redefining key aspects of Mexico’s pharmaceutical regulatory framework in line with commitments under the USMCA. The changes… [](/en_GB/new/mexico-amendment-health-supplies-regulations-strengthens-protection-pharmaceutical-innovation) - 01 / 21 / 2026 [### Mexico updates its legislation with key reforms and amendments in connection with health regulated products and services](/en_GB/new/mexico-updates-its-legislation-key-reforms-and-amendments-connection-health-regulated-products) On January 15, 2026, a decree was published in the Federal Official Gazette establishing considerable amendments to the General Health Law. The amendments strengthen the powers of health authorities and introduce new restrictions, control mechanisms… [](/en_GB/new/mexico-updates-its-legislation-key-reforms-and-amendments-connection-health-regulated-products) - 01 / 21 / 2026 [### Mexico 2026: The Main Legal Keys for Businesses](/en_GB/new/mexico-2026-main-legal-keys-businesses) Specialists from the different areas of practice of Garrigues in Mexico analyse, from all perspectives of business law, the main regulatory developments that will impact companies in the country this year. [](/en_GB/new/mexico-2026-main-legal-keys-businesses) - 09 / 05 / 2025 [### Mexico: Government promotes reforms and amendments to health legislation to strengthen control of health products and services](/en_GB/new/mexico-government-promotes-reforms-and-amendments-health-legislation-strengthen-control-health) In recent years, the regulatory framework in the field of health has undergone a profound transformation. Recent reforms seek to strengthen the protection of public health, regulate sensitive products and services, and expand the powers of health… [](/en_GB/new/mexico-government-promotes-reforms-and-amendments-health-legislation-strengthen-control-health) [See more](../../en_GB/publications/list?f[0]=service%3A1429)